Narayana Hrudayalaya Limited (NSE:NH)
India · Delayed Price · Currency is INR 1,760.00
-17.80 (-1.00%)
Aug 8, 2025, 11:30 AM IST
Paycor HCM Market Cap
Narayana Hrudayalaya has a market cap or net worth of 361.07 billion as of August 7, 2025. Its market cap has increased by 41.62% in one year.
Market Cap
361.07B
Enterprise Value
369.11B
Revenue
56.84B
Ranking
n/a
PE Ratio
46.02
Stock Price
$1,760.00
Market Cap Chart
Since January 6, 2016, Narayana Hrudayalaya's market cap has increased from 68.17B to 361.07B, an increase of 429.65%. That is a compound annual growth rate of 18.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 361.07B | 39.68% |
| Dec 31, 2024 | 258.51B | 5.91% |
| Dec 29, 2023 | 244.08B | 58.15% |
| Dec 30, 2022 | 154.34B | 18.94% |
| Dec 31, 2021 | 129.77B | 42.72% |
| Dec 31, 2020 | 90.93B | 45.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,827.42B |
| Divi's Laboratories | 1,628.25B |
| Cipla | 1,200.88B |
| Mankind Pharma | 1,055.02B |
| Apollo Hospitals Enterprise | 1,033.74B |
| Zydus Lifesciences | 938.51B |
| Fortis Healthcare | 647.87B |
| Aurobindo Pharma | 622.79B |